Skip to main content
. 2019 Feb 4;81(3):466–472. doi: 10.1292/jvms.18-0754

Table 3. Virucidal and bactericidal efficacies of GSE against viruses and bacteria in aqueous phase.

Pathogen AIV
NDV
IBDV
SI
EC
FBS 0% 5% 0% 5% 0% 5% 0% 5% 0% 5%
Positive control 6.50 ± 0.07a) 6.75 ± 0.00 7.00 ± 0.12 6.75 ± 0.00 6.84 ± 0.21 NTb) 8.30 ± 0.19 7.73 ± 0.19 7.98 ± 0.25 7.23 ± 0.16

Titer / number of colonies ×100 0 secc) 4.91 ± 0.35 5.00 ± 0.00 7.00 ± 0.00 6.63 ± 0.06 5.62 ± 0.04 NT 5.88 ± 0.51 7.30 ± 0.00 7.15 ± 0.01 6.40 ± 0.25
5 sec 3.08 ± 0.17 3.91 ± 0.37 <2.50 ± 0.00 3.50 ± 0.00 5.61 ± 0.07 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00
10 sec 2.83 ± 0.16 <2.50 ± 0.00 <2.50 ± 0.00 3.50 ± 0.00 5.60 ± 0.10 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00
30 sec 2.83 ± 0.16 <2.50 ± 0.00 <2.50 ± 0.00 3.50 ± 0.00 5.44 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00

×500 0 sec 5.75 ± 0.07 5.25 ± 0.00 7.00 ± 0.00 6.75 ± 0.00 5.81 ± 0.21 NT 7.41 ± 0.24 6.84 ± 0.11 7.72 ± 0.09 6.73 ± 0.08
5 sec 4.41 ± 0.24 5.66 ± 0.04 <2.50 ± 0.00 6.66 ± 0.04 5.70 ± 0.05 <2.60 ± 0.00 3.03 ± 0.20 <2.60 ± 0.00 3.76 ± 0.54
10 sec 4.16 ± 0.35 5.91 ± 0.14 <2.50 ± 0.00 6.16 ± 0.14 5.67 ± 0.07 <2.60 ± 0.00 3.42 ± 0.38 <2.60 ± 0.00 3.53 ± 0.44
30 sec 3.16 ± 0.17 5.91 ± 0.14 <2.50 ± 0.00 5.33 ± 0.20 5.73 ± 0.06 <2.60 ± 0.00 <2.60 ± 0.00 <2.60 ± 0.00 2.86 ± 0.07

×1,000 0 sec 6.00 ± 0.11 5.63 ± 0.18 6.88 ± 0.06 6.50 ± 0.00 6.25 ± 0.13 NT 7.58 ± 0.28 7.24 ± 0.36 7.55 ± 0.03 6.75 ± 0.07
5 sec 5.33 ± 0.32 5.91 ± 0.04 <2.50 ± 0.00 7.00 ± 0.07 5.76 ± 0.06 <2.60 ± 0.00 4.13 ± 0.36 <2.60 ± 0.00 3.99 ± 0.50
10 sec 5.41 ± 0.20 5.83 ± 0.04 <2.50 ± 0.00 7.00 ± 0.07 5.71 ± 0.06 <2.60 ± 0.00 3.09 ± 0.23 <2.60 ± 0.00 3.58 ± 0.46
30 sec 5.16 ± 0.39 6.16 ± 0.10 <2.50 ± 0.00 7.08 ± 0.10 5.73 ± 0.06 <2.60 ± 0.00 2.98 ± 0.18 <2.60 ± 0.00 3.05 ± 0.21

a) Virus titer or colony counts are shown in log10, b) Not Tested, c) Reaction time. Data are expressed as the mean of three experiments ± standard deviation.